Ophthalmic Drugs Conference

London, United Kingdom

The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.

With that in mind, We are proud to present the 3rd Annual Ophthalmic Drugs Conference taking place on the 19th-20th of November 2019, in London.

As Europe's leading Ophthalmic Drugs conference, we will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort, and regulatory compliance which make up such core components within the Ophthalmic Drug sphere.

This three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.

We look forward to welcoming you to the conference in November.

Early registration is strongly advised to avoid disappointment.

Benefits of Attending

  • Explore novel approaches to delivery of ocular drugs
  • Understand late-stage clinical development programs through real-world examples
  • Delve into novel delivery methods for ophthalmic drugs via implants lenses and punctal plugs
  • Learn how micro-dosing technologies are being used for the treatment of ocular disease
  • New for 2019: focus day on the challenges of drug delivery through a complex barrier

Who should attend

Key Job Titles:
Chief, Vice Presidents, Heads, Senior Directors, Directors, Principals, Principal Scientists, Team/ Project Leaders, Clinicians, Clinical Trial Managers, Medical Officers of:
  • Ophthalmology
  • Ophthalmic devices
  • Drug Delivery
  • Drug discovery
  • Research and development
  • Clinical development
  • Quality assurance
  • Immunology, Inflammation and Allergies
  • Market Access
Global Presence:
Attendees from all over the world attend our events, gain hands on insight from representatives from UK, Europe and USA.

Focus Day Chair:

  • Peter Morgan-Warren, Medical Assessor, MHRA

Focus Day Featured Speakers:

  • Michael Burr, Vice President of Product Development,iVeena
  • Simon Chandler, Executive Director, Clinical Development, Allergan
  • Jinzhong Zhang, Vice President, Graybug Vision
  • Borja Salvador-Culla, Anterior Segment, Cornea and Refractive Surgery Consultant in Ophthalmology, Centro de Oftalmologia Barraquer
  • Clive Wilson, Research Professor, Strathclyde Institute of Pharmacy and Biomedical Sciences

Conference Chairs for 2019:

  • Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals
  • Naj Sharif, Vice President, Global Ophthalmology, Santen Inc, USA

Conference Featured 2019 Speakers Include:

  • Parisa Zamiri, Global Head of Clinical Development in Ophthalmology, Novartis Pharmaceutical inc.
  • Gavin Spencer, Executive Vice President and Chief Business Officer, Nicox
  • Aniz Girach, Chief Medical Officer, ProQR Therapeutics
  • Daniel Chung, Global Medical Strategy Lead-Ophthalmology, Spark Therapeutics
  • Michael Ehrlich, Senior Clinical Program Lead - Retinopathies, Boehringer Ingelheim
  • Peter Morgan-Warren, Medical Assessor, MHRA
  • William Dallman, Clinical Development Manager, Eyenuk
Focus Day - November 18th

Conference Day One - November 19th

Conference Day Two - November 20th


Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK

Event details
Organizer : SMi
Event type : Conference
Reference : ASDE-21500